CME Information - EQIPP: Asthma

EQIPP: Asthma - Diagnosing and Managing in Pediatrics

ACCME Accreditation Statement

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 14 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAP designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. All stages of the activity must be completed for a participant to claim any credit. Approval is valid until January 25, 2016. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with the AAPA's CME Standards.

This program is approved for 34 NAPNAP CE contact hours of which 4.5 contain pharmacology (Rx) content per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.

This activity is acceptable for a maximum of 34 credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

Purpose of Course

The goals of this EQIPP: Asthma - Diagnosing and Managing in Pediatrics course are to help you create a plan for improvement to address gaps you identify in key clinical activities of asthma care. By using EQIPP, you will collect data to measure your current level of care at baseline as you work to improve care through Plan, Do, Study, Act (PDSA) cycles.

Learning Objectives

By the end of the EQIPP: Asthma - Diagnosing and Managing in Pediatrics course, you will use the learn

Collect and analyze baseline data to establish a starting point for improvement.
Identify one or more quality gaps in one or more key clinical activities of asthma care.
Create an improvement plan for closing the quality gap(s) in which you
Implement change(s) designed to close the quality gap(s).
Collect and analyze follow-up data to measure the results of your improvement efforts.
Create additional improvement plans and repeat the change-improvement cycle until you reach your goal of providing the best possible asthma care to patients.

Measure and improve care delivery and processes concerning Asthma services by doing the following:
- Collect and analyze baseline data to establish a starting point for improvement.
- Identify one or more performance gaps in one or more key activities of Asthma care.
- Create an improvement plan for closing identified performance gap(s) by clarifying the improvement idea to be tested:
  
  AIM: What are we trying to improve or accomplish?
  
  MEASURES: How will we know that a change made is an improvement?
  
  CHANGES: What changes can we make that will result in improvement?
- Test your ideas quickly, on a small scale, so you can determine if the changes lead to improvement.
- Collect and analyze follow-up data to measure the results of your test.
- Determine how to sustain successful changes and how to systematically integrate them into the culture, processes, and workflow of your practice.
- Create additional improvement plans and repeat PDSA cycles until you reach the maximum potential of providing optimal newborn screening for infants in your practice.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

The AAP CME program aims to develop, maintain, and improve the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME program strives to meet participants' educational needs and support their life-long learning with a goal of improving care for children and families. (AAP CME Program Mission Statement, September 2010)

The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP sponsored or jointly sponsored Continuing Medical Education (CME) activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity (ACCME Standard 1.1).

The purpose of this policy and its associated procedures is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good.

The content of this CME activity does not necessarily reflect the views or policies of the AAP.

Disclosure of Financial Relationships

All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. *Commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Name	Relevant Financial Relationship (Please indicate Yes or No)	Name of Commercial Interest(s)* (Please list name(s) of entity) AND Nature of Relevant Financial Relationship(s) (Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other - identify)	Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical. (Do intend to discuss or Do not intend to discuss)
Bradley Chipps, MD, FAAP (SME)	Yes	1. I have a Speakers' Bureau relationship with Alcon Please note: Advisor for Consult; Grants for Clinical Resea Added 09/29/2011 by Bradley Chipps, source=Web Response 2. I have a Speakers' Bureau relationship with Genentech Please note: Advisor for Consult; Grants for Clinical Resea Added 09/29/2011 by Bradley Chipps, source=Web Response 3. I have a Honorarium relationship with AstraZeneca Please note: Advisor for Consult; Grants for Clinical Resea Added 09/29/2011 by Bradley Chipps, source=Web Response 4. I have a Speakers' Bureau relationship with GlaxoSmithCl Please note: Advisor for Consult; Grants for Clinical Resea Added 09/29/2011 by Bradley Chipps, source=Web Response 5. I have a Speakers' Bureau relationship with Meda Please note: Advisor for Clinical Consult Added 09/29/2011 by Bradley Chipps, source=Web Response 6. I have a Speakers' Bureau relationship with Novartis Please note: Advisor for Clinical Consult; Grants for Clinic Added 09/29/2011 by Bradley Chipps, source=Web Response 7. I have a Speakers' Bureau relationship with Sunovion Please note: Advisor for Clinical Consult; Grants for Clinic Added 09/29/2011 by Bradley Chipps, source=Web Response 8. I have a Speakers' Bureau relationship with Merck-Scheri Please note: Advisor for Clinical Consult; Grants for Clinic Added 09/29/2011 by Bradley Chipps, source=Web Response 9. I have a Speakers' Bureau relationship with ISTA Please note: Advisor for Consult Added 09/29/2011 by Bradley Chipps, source=Web Response 10. I have a Advisor for Consult relationship with Quintiles Added 09/29/2011 by Bradley Chipps, source=Web Response 11. I have a Speakers' Bureau relationship with Dey Please note: Advisor for Consult Added 09/29/2011 by Bradley Chipps, source=Web Response	Do not intend to discuss
Julie Katkin, MD, FAAP (SME)	No	None	Do not intend to discuss
Daniel Rauch, MD, FAAP (SME)	No	None	Do not intend to discuss
HeowCh'ng Ang (Staff)	No	None	Do intend to discuss
Tamiko O'Brill (Staff)	No	None	Do intend to discuss

Original Authors

Bradley Chipps, MD, FAAP, FAAAI, FCCP

Capital Allergy & Respiratory Disease Center

Sacramento, CA 95819

Bruce M Schnapf, DO, FAAP

(Fellow of American College of Chest Physicians

and American Thoracic Society)

Associate Professor of Pediatrics

Division Chief, Pulmonology

University of South Florida College of Medicine

Tampa, FL

Chris Landon, MD, FAAP, FCCP, CMD

Director of Pediatrics

Ventura County Medical Center

Ventura, CA 93003

Mark L Corbett, MD, FAAAAI, FACAAI

Associate Clinical Professor of Pediatrics

Section of Allergy & Immunology

University of Louisville

Louisville, KY 40207

Todd A Mahr, MD, FAAP, FAAAAI, FACAAI

Director, Pediatric Allergy & Immunology

Gundersen Lutheran Medical Center

LaCrosse, WI 54601

Michael Mellon, MD, FAAP

Associate Professor Pediatrics

UCSA School of Medicine

La Jolla, CA

Daniel A. Rauch, MD, FAAP

Director, Pediatric Hospitalist Program

New York University School of Medicine

Scarsdale, NY 10583

Susan Chu Walley, MD, FAAP

Pediatric Hospitalist

The Children’s Hospital, Birmingham, AL

Birmingham, AL 35233

Elizabeth L. Robbins, MD, FAAP

Pediatric Hospitalist

Anne Arundel Medical Center

Annopolis, MD 21409

Commercial Supporters

The EQIPP: Asthma - Diagnosing and Managing in Pediatrics course is supported, in part, by Boehringer Ingelheim

Product-Specific Advertising

No product-specific advertising of any type appears in this activity. No links to product websites appear in this activity.

List of EQIPP: Managing Asthma in Pediatrics II Principal Faculty and Credentials

Bradley Chipps, MD, FAAP, FAAAI, FCCP

Bruce M Schnapf, DO, FAAP

Chris Landon, MD, FAAP, FCCP, CMD

Mark L Corbett, MD, FAAAAI, FACAAI

Todd A Mahr, MD, FAAP, FAAAAI, FACAAI

Michael Mellon, MD, FAAP

Daniel A. Rauch, MD, FAAP

Susan Chu Walley, MD, FAAP

Elizabeth L. Robbins, MD, FAAP

AAP Staff

Tamiko O'Brill

Instructional Designer

HeowCh'ng Ang

Name of Medium or Combination of Media Used

Internet course

Method of physician participation in the learning process

The EQIPP: Asthma - Diagnosing and Managing in Pediatrics course requires you to do some work online and some offline. The online work involves reviewing the content presentation, researching linked information, and participating in guided activities. The offline work includes the performance improvement activities you will do within your own practice to improve the Newborn Screening key activities in your practice.

Please note: CME credit is only awarded to learners who enter and analyze data. Using sample data provided by EQIPP will exclude learners from receiving AMA Category 1 Credit for the performance improvement activity portion of the course.

Estimated time to complete the educational activity

You may progress through the course at a pace that is comfortable for you, taking into consideration the demands of your practice. But it is important to establish a goal for completion. The amount of time you are likely to spend per clinical content area can vary depending on if you pursue additional links for more learning. You may also want to consider some elapsed time between sections to “catch your breath.”

Completion requirements for the Performance Improvement activity include:

Enter baseline data and analyze your results.
Create an improvement plan that has a minimum of 1 aim statement.
Document a minimum of 1 idea for change
Enter data for a minimum of one follow up data set and analyze your results.
Submit a course evaluation.

Generally speaking, the EQIPP: Asthma - Diagnosing and Managing in Pediatrics course can be completed within 4-8 months, depending on the number of improvement cycles you make to reach the goals you have set for your practice.

Dates of Original Release and Most Recent Review or Revision

This course was launched on January 25, 2013.

Termination Date

This course will remain online until January 25, 2016. It will no longer be certified for credit after January 25, 2016.

List of Hardware/Software Requirements

Recommended browsers:

Internet Explorer 6.0 and above
Firefox 2.0 and above
Safari 1.3.2 and above
Opera 7.5 and above

Recommended browser settings:

JavaScript enabled
Cookies enabled
SSL 2.0 & SSL 3.0 enabled
Flash Player Plug-in (version 7.0 +)
Adobe Reader Plug-in (version 6.0 +)

Provider Contact information

If you have questions about this course or encounter technical problems, please contact PediaLink at [email protected]. Subject: EQIPP: Asthma - Diagnosing and Managing in Pediatrics

Privacy and Confidentiality Statement

At the American Academy of Pediatrics, we take the issue of privacy very seriously. We do not sell, distribute, barter, or transfer personally identifiable information obtained from a user to a third party. Any information collected on the Web site is only used for the purpose stated.

The AAP list is only for important Academy communications, and your e-mail address will not be sold or provided to third parties. You will not receive advertising or promotional material on this list.

The American Academy of Pediatrics may use "cookie" technology to obtain non-personal information from its online visitors. We do not extract personal information in this process nor do we provide this information to third parties. We also do not contact you based on information in your cookie file.

The American Academy of Pediatrics has taken steps to make all information received from our online visitors as secure as possible against unauthorized access and use. All information is protected by our security measures, which are periodically reviewed.